In fact, it is well known that TI correlates with longer OS, and our group demonstrated in 1145 cases of LR‐MDS that a favourable effect of ESA (compared to non‐treatment) was suggested for patients with Hb 8–10 g/dL. The gene discussed is GSTM1; the disease is myelodysplastic syndrome.